Text and Data Mining valid from 2020-04-09
Received: 16 December 2019
Accepted: 31 March 2020
First Online: 9 April 2020
Ethics approval and consent to participate
: This research was approved by the institutional ethics committee.
: Awaiver of consent for this research was approved by the institutional ethics committee.
: Thomas J Borody has a pecuniary interest in the Centre for Digestive Disease and has filed patents for antibiotic therapies in Crohn’s disease and faecal microbiota transplant. Dr. Agrawal, Dr. Clancy and Dr. Huynh have no disclosures.